ALAMEDA, Calif.--(BUSINESS WIRE)--
InSite Vision Incorporated (OTCBB: INSV) will hold its Annual Meeting of
Stockholders at 10:00 a.m. Pacific Time on Wednesday, July 16, 2014 at
the company's headquarters at 965 Atlantic Avenue, Alameda, California.
Company management will host a live webcast of the meeting, including a
corporate presentation, available on the Investor Relations page of the
company's website (www.insitevision.com).
For those who miss the live broadcast, an archived replay will be
available shortly thereafter.
Analysts and investors can listen to the Annual Meeting via conference
call by dialing 866-515-2911 for domestic callers and 617-399-5125 for
international callers and entering the pass code 98634471.
About InSite Vision
InSite Vision is advancing new ophthalmologic products for unmet eye
care needs based on its innovative DuraSite® platform
technologies. The DuraSite and DuraSite 2 drug delivery systems extend
the duration of drug retention on the surface of the eye, thereby
reducing the frequency of treatment and improving the efficacy of
The DuraSite platform is currently leveraged in two commercial products
for the treatment of bacterial eye infections, AzaSite®
(azithromycin ophthalmic solution) 1%, marketed in the U.S. by Akorn
Inc.; and Besivance® (besifloxacin ophthalmic suspension)
0.6%, marketed by Bausch + Lomb, a wholly owned subsidiary of Valeant
Pharmaceuticals International. InSite Vision is also advancing AzaSite
Plus™, a novel ophthalmic therapeutics through Phase 3
clinical studies for the treatment of eye infections, and is preparing
two new drug applications (NDA) for the commercial approval by the U.S.
Food & Drug Administration (FDA): BromSite™ for the
treatment of inflammation and prevention of pain associated with
cataract surgery and DexaSite™ for the treatment of
blepharitis. For further information on InSite Vision, please visit www.insitevision.com.
Louis Drapeau, 510-747-1220
and Investor inquiries
Karen L. Bergman, 650-575-1509
Source: InSite Vision Incorporated